 |
|
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Clin Mol Hepatol. 2023;29(3):593-604. Published online 2023 Feb 13 DOI: https://doi.org/10.3350/cmh.2022.0391
|
|
Citations to this article as recorded by
 Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?
Stefan Patauner, Giovanni Scotton, Francesca Notte, Antonio Frena
World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma
Fan Wu, Xin Kuang, Sanlin Deng, Shuo Qi, Jian Xiong, Bibo Zhao, Chuanfu Li, Senyou Tan, Qiang Kang, Hao Xiao, Xiaofeng Tan, Gui-long Wu, Qinglai Yang, Guodong Chen
Materials Today Bio.2025; 30: 101442. CrossRef HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
Shuangyan Tang, Feng Shi, Yi Xiao, Hongjie Cai, Ping Ma, Yuanmin Zhou, Zhiqiang Wu, Song Chen, Wenbo Guo
Hepatology International.2025; 19(1): 106. CrossRef Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma
Huangpeng Lin, Zexian Ma, Jin Li, Heping Zhu, Xuefeng Huang, Huimin Chen, Liang Tu, Yifan Lian, Yongjie Su
Frontiers in Immunology.2025;[Epub] CrossRef Efficacy and safety of neoadjuvant therapy for hepatocellular carcinoma with portal vein thrombosis: A meta‑analysis
Wangyi Xuan, Xiaoming Zhang, Yingying Fang, Yueming Zhang, Zhiyi Xiang, Yifei Yu, Qingping Wu, Xingfen Zhang
Oncology Letters.2025;[Epub] CrossRef Anticipation for hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma
Grigorios Christodoulidis, Dimitra Bartzi, Konstantinos E Koumarelas
World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef SERPINH1 secretion by cancer-associated fibroblasts promotes hepatocellular carcinoma malignancy through SENP3-mediated SP1/SQLE pathway
Hua Xiao, Zhaoying Yao, Tao Li, Xin Fang, Xuejiao Xu, Sheng Hu, Ya Yang, Chenchen Jin, Yuxiang Fei, Chao Liu, Qianming Du
International Immunopharmacology.2025; 150: 114259. CrossRef Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis
Lingling Zhao, Cheng Xu, Jiewen Deng, Yang Ni
Frontiers in Oncology.2025;[Epub] CrossRef Neoadjuvant therapy for hepatocellular carcinoma—priming precision innovations to transform HCC treatment
Kristin E. Goodsell, Alice J. Tao, James O. Park
Frontiers in Surgery.2025;[Epub] CrossRef Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review
Ying Wu, Zhenpeng Zeng, Shuanggang Chen, Danyang Zhou, Gangling Tong, Duanming Du
Frontiers in Immunology.2025;[Epub] CrossRef A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014–2023
Qi-Feng Chen, Xiong-Ying Jiang, Min-Shan Chen, Ning Lyu, Ming Zhao
Annals of Surgery Open.2025; 6(1): e562. CrossRef Hepatic arterial infusion chemotherapy combined with lenvatinib and immune checkpoint inhibitor versus lenvatinib for advanced hepatocellular carcinoma: a multicenter study with propensity score and coarsened exact matching
Qunfang Zhou, Hui Li, Ye Liang, Ruixia Li, Xiaohui Wang, Wei Wang, Mingyu Liu, Feng Duan, Zhimei Huang
La radiologia medica.2025; 130(5): 662. CrossRef Future perspectives on immunotherapy for hepatocellular carcinoma
Landon L. Chan, Stephen L. Chan
Therapeutic Advances in Medical Oncology.2025;[Epub] CrossRef Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma
Jing Yan, Rui An, Jing-Jing Wang, Min Wang, Qi Zhao, Shen Zhao, Jian Xu
World Journal of Gastrointestinal Surgery.2025;[Epub] CrossRef Hepatic arterial infusion chemotherapy versus transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
Yi Zhang, Ze Zhang, Xiaoxv Yin, Anhui Xu, Yonghong Hao, Nan Jiang, Ruibing Zhou, Ketao Mu
European Radiology.2025;[Epub] CrossRef Advances in transarterial chemoembolization for hepatocellular carcinoma: Integration with systemic therapies and emerging treatment strategies
Henry Sutanto, Galih Januar Adytia, Elisa Elisa, Ummi Maimunah
Cancer Pathogenesis and Therapy.2025;[Epub] CrossRef A network meta-analysis of different interventional treatment strategies for unresectable hepatocellular carcinoma
Xing-Yan Le, Jun-Bang Feng, Xiao-Li Yu, Sui-Li Li, Xiaocai Zhang, Jiaqing Li, Chuan-Ming Li
BMC Gastroenterology.2025;[Epub] CrossRef Natural born Killers: Harnessing NK cells to treat cancer
Kanchi Patell, Katherine Myers, Amr Mohamed, David Wald, J. Eva Selfridge
Best Practice & Research Clinical Haematology.2025; 38(3): 101630. CrossRef Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging
Weihao Zhang, Xiaohui Zhao, Wei Gao, Tongguo Si, Qiang Zou, Xueling Yang, Wenge Xing, Haipeng Yu
Frontiers in Immunology.2025;[Epub] CrossRef Adjuvant chemotherapy improves post-transplant outcome in patients with hepatocellular carcinoma
Heng-Kai Zhu, Hai-Bo Mou, Zhuo-Yi Wang, Wu Zhang, Dan Zhu, Si-Yi Zhong, Shu-Sen Zheng, Li Zhuang
Hepatobiliary & Pancreatic Diseases International.2025;[Epub] CrossRef Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning
Fan Yao, Jianliang Miao, Bing Quan, Jinghuan Li, Bei Tang, Shenxin Lu, Xin Yin
Journal of Hepatocellular Carcinoma.2025; Volume 12: 1111. CrossRef Transarterial chemoembolization combined with intra-arterial infusion of sintilimab and bevacizumab for advanced hepatocellular carcinoma: a phase 2 study
Mao-Yuan Mu, Zi-Xiong Chen, Yu-Zhe Cao, Xiao-Bo Fu, Li-Jie Qiu, Han Qi, Fei Gao
Cancer Letters.2025; 628: 217851. CrossRef Comprehensive multi-omics analysis of bile acid metabolism in hepatocellular carcinoma: implications for prognosis, immune microenvironment, and therapeutic resistance
Jiayan Ma, Ming Cheng, Limin Jin, Yong Wang, Zhengyang Feng, Yuntian Shen, Yaqun Zhu, Qiliang Peng
Clinical and Translational Oncology.2025;[Epub] CrossRef Establishment of a prognostic nomogram and risk stratification system for patients with distant-metastatic hepatocellular carcinoma: A population-based study
Qiuhan Heng, Ying Leng, Gang Bai, Hua Yu
Medicine.2025; 104(24): e42834. CrossRef Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma
Jiaqi Wang, Chuchu Ma, Zhongyuan Tang, Zhengwu Sun, Eskandar Qaed, Xinming Chi, Jun Wang, Yazeed Jamalat, Zhaohong Geng, Zeyao Tang, Qiying Yao
Cancer Cell International.2024;[Epub] CrossRef Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study
Tao Xue, Hongbin Yu, Wenming Feng, Yao Wang, Shiyong Wu, Lili Wang, Peiqin Zhu, Jianming Guan, Quan Sun
Cancer Management and Research.2024; Volume 16: 163. CrossRef Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Ming‐Da Wang, Xue‐Jun Xu, Ke‐Chun Wang, Yong‐Kang Diao, Jia‐Hao Xu, Li‐Hui Gu, Lan‐Qing Yao, Chao Li, Guo‐Yue Lv, Tian Yang
Cancer Science.2024; 115(7): 2159. CrossRef Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study
Jae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Suho Kim, Jung Suk Oh, Ho Jong Chun, Pil Soo Sung
Abdominal Radiology.2024; 49(9): 3127. CrossRef The Immune Inductive Role of Hepatic Arterial Infusion Chemotherapy Prior to Atezolizumab Plus Bevacizumab Combination Therapy in Hepatocellular Carcinoma
Hiroyuki Suzuki, Miwa Sakai, Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Masahito Nakano, Tomotake Shirono, Yu Noda, Etsuko Moriyama, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Gastro Hep Advances.2024; 3(4): 506. CrossRef Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
Oncology Letters.2024;[Epub] CrossRef Combining liver-directed and immunotherapy in advanced hepatocellular carcinoma: A review and future directions
Pranav Kumar, Chase J. Wehrle, Keyue Sun, Chunbao Jiao, Rebecca Panconesi, Mingyi Zhang, Noah X. Tocci, Hanna Hong, Abby Gross, Erlind Allkushi, Maureen Whitsett Linganna, Andrea Schlegel, Toms Augustin, Charles Miller, David CH Kwon, Kazunari Sasaki, Fed
Surgical Oncology Insight.2024; 1(4): 100100. CrossRef Efficacy and safety of HAIC-FOLFOX plus tyrosine kinase inhibitors and immune checkpoint inhibitors as first-line treatment for unresectable advanced hepatocellular carcinoma: A systematic review and meta-analysis
Peng Jiang, Chao Chen, Jing Tian, Fan Yang, Zhen-yu Jiang, An-xiang Hu, Bin Liu
Academic Radiology.2024;[Epub] CrossRef Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy
Eda Caliskan Yildirim, Yakup Ergun
World Journal of Gastrointestinal Oncology.2024; 16(12): 4757. CrossRef Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
Ji Yeon Lee, Jaejun Lee, Suho Kim, Jae-sung Yoo, Ji Hoon Kim, Keungmo Yang, Ji Won Han, Jeong Won Jang, Jong Yong Choi, Seung Kew Yoon, Ho Jong Chun, Jung Suk Oh, Pil Soo Sung
Frontiers in Oncology.2024;[Epub] CrossRef Bavachin stimulates ferroptosis and reduces malignant phenotype progression of hepatocellular carcinoma cells by inducing lipid peroxidation by modulation of the Nrf2/HO-1 signaling pathway
Haoyu Li
American Journal of Translational Research.2024; 16(11): 6925. CrossRef Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
Clinical and Molecular Hepatology.2023; 29(2): 242. CrossRef Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization
Long-Wang Lin, Kun Ke, Le-Ye Yan, Rong Chen, Jing-Yao Huang
Frontiers in Oncology.2023;[Epub] CrossRef Case Report: Clinical application of continuous arterial infusion chemotherapy in neoadjuvant therapy for locally advanced gastric cancer
Wenli Lin, Zhongxian Huang, Zhenhua Du, Yunshan Wang, Taiyang Zuo
Frontiers in Oncology.2023;[Epub] CrossRef
|